These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 24841412

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures.
    Valente EG, Vernet D, Ferrini MG, Qian A, Rajfer J, Gonzalez-Cadavid NF.
    Nitric Oxide; 2003 Dec; 9(4):229-44. PubMed ID: 14996430
    [Abstract] [Full Text] [Related]

  • 23. Intratunical injection of stromal vascular fraction prevents fibrosis in a rat model of Peyronie's disease.
    Castiglione F, Hedlund P, Weyne E, Hakim L, Montorsi F, Salonia A, Bivalacqua TJ, De Ridder D, Milenkovic U, Ralph D, Garaffa G, Muneer A, Joniau S, Albersen M, Trauma and Reconstructive Urology Working Party of the European Association of Urology (EAU) Young Academic Urologists (YAU).
    BJU Int; 2019 Aug; 124(2):342-348. PubMed ID: 30267556
    [Abstract] [Full Text] [Related]

  • 24. Effect of Penile Traction and Vacuum Erectile Device for Peyronie's Disease in an Animal Model.
    Lin H, Liu C, Wang R.
    J Sex Med; 2017 Oct; 14(10):1270-1276. PubMed ID: 28923308
    [Abstract] [Full Text] [Related]

  • 25. Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease.
    Ferrini MG, Kovanecz I, Nolazco G, Rajfer J, Gonzalez-Cadavid NF.
    BJU Int; 2006 Mar; 97(3):625-33. PubMed ID: 16469038
    [Abstract] [Full Text] [Related]

  • 26. Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts.
    Cho JS, Moon YM, Park IH, Um JY, Moon JH, Park SJ, Lee SH, Kang HJ, Lee HM.
    Clin Exp Allergy; 2012 Jun; 42(6):872-82. PubMed ID: 22239687
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Kindlin-2 mediates Peyronie's disease through activation of TGF-β/Smad signaling pathway under the presence of TGF-β1.
    Yang X, Wu J, Cai T, Shan J, Cui Y.
    Cell Signal; 2024 Sep; 121():111286. PubMed ID: 38977232
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Experimental models of Peyronie's disease. Implications for new therapies.
    Gonzalez-Cadavid NF, Rajfer J.
    J Sex Med; 2009 Feb; 6(2):303-13. PubMed ID: 19138365
    [Abstract] [Full Text] [Related]

  • 31. RNA-sequencing profiling analysis of pericyte-derived extracellular vesicle-mimetic nanovesicles-regulated genes in primary cultured fibroblasts from normal and Peyronie's disease penile tunica albuginea.
    Yin GN, Piao S, Liu Z, Wang L, Ock J, Kwon MH, Kim DK, Gho YS, Suh JK, Ryu JK.
    BMC Urol; 2021 Aug 06; 21(1):103. PubMed ID: 34362357
    [Abstract] [Full Text] [Related]

  • 32. Simvastatin and the Rho-kinase inhibitor Y-27632 prevent myofibroblast transformation in Peyronie's disease-derived fibroblasts via inhibition of YAP/TAZ nuclear translocation.
    Milenkovic U, Ilg MM, Zuccato C, Ramazani Y, De Ridder D, Albersen M.
    BJU Int; 2019 Apr 06; 123(4):703-715. PubMed ID: 30536599
    [Abstract] [Full Text] [Related]

  • 33. A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques.
    Jung KH, Ryu YL, Lee HS, Lee H, Son MK, Yan HH, Hong SW, Ryu JK, Hong S, Suh JK, Hong SS.
    Int J Oncol; 2013 Jun 06; 42(6):2001-8. PubMed ID: 23588860
    [Abstract] [Full Text] [Related]

  • 34. MicroRNA-29b attenuates fibrosis in a rat model of Peyronie's disease.
    Candido P, Pimenta R, Maluf FC, Chiovatto C, Romão P, Baldavira CM, Ghazarian V, Camargo JA, Guimarães VR, Santos GAD, Silva IA, Nascimento B, Hallak J, Capelozzi VL, Srougi M, Nahas WC, Viana NI, Leite KR, Reis ST.
    Andrology; 2024 Jun 24. PubMed ID: 38925608
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The anti-inflammatory and antifibrosis effects of anthocyanin extracted from black soybean on a Peyronie disease rat model.
    Sohn DW, Bae WJ, Kim HS, Kim SW, Kim SW.
    Urology; 2014 Nov 24; 84(5):1112-6. PubMed ID: 25156514
    [Abstract] [Full Text] [Related]

  • 38. Rat as an animal model for Peyronie's disease research: a review of current methods and the peer-reviewed literature.
    Chung E, De Young L, Brock GB.
    Int J Impot Res; 2011 Nov 24; 23(6):235-41. PubMed ID: 21776004
    [Abstract] [Full Text] [Related]

  • 39. Temporal gene signature of myofibroblast transformation in Peyronie's disease: first insights into the molecular mechanisms of irreversibility.
    Ilg MM, Harding S, Lapthorn AR, Kirvell S, Ralph DJ, Bustin SA, Ball G, Cellek S.
    J Sex Med; 2024 Mar 28; 21(4):278-287. PubMed ID: 38383071
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.